Skip to main content
New England Journal of Medicine
Second-Line Switch to Dolutegravir for Treatment of HIV Infection Publication in the New England Journal of Medicine
The primary end point was a plasma HIV type 1 RNA level of at least 50 copies per milliliter at week 48, assessed on the basis of the Food and Drug Administration snapshot algorithm.
Dr. Loice Achieng
Co-Founder at CEMA Selected for WHO Expert Committee
The Expert Committee is responsible for updating the WHO Model List of Essential Medicines
WSU and UoN Collaboration
WSU and UoN in joint program for phd students
The Washington State University President, Prof. Kirk Schulz visited the University of Nairobi to strengthen collaboration between the two institutions.
CEMA-Seminar Series Antibiotic Resistance Uganda
CEMA-Africa Seminar Series - February 2023
Topic: Production system drivers of antibiotic resistance at the human-animal interface in Uganda
Publication_TSM_Rabies
A call to accelerate an end to human rabies deaths
Every year, an estimated 59 000 vaccine-preventable deaths occur globally due to rabies.
COVID-19 situation report for WHO Africa Region 06/10/2022
COVID-19 situation report for WHO Africa Region 06/10/2022
COVID-19 situation report for WHO Africa Region - 6th October 2022